Clinical Trials in Los Angeles

Showing 8021-8040 of 12,794 trials

Beta Cell Restoration Through Fat Mitigation

NCT01763346

Weight loss achieved through gastric banding will be superior to treatment with metformin in preserving or restoring pancreatic beta cell function in people with prediabetes or mild type 2 diabetes.

PrediabetesType 2 DiabetesObesity

University of Southern California88 participantsStarted Jun 2013

Los Angeles, California, United States

COMPLETEDPhase 4< 1 mile

Brain Aging and Treatment Response in Geriatric Depression

NCT01902004

The proposed project will evaluate the role of neuroimaging biomarkers of brain aging (i.e., neurodegenerative and vascular brain changes) and mild cognitive impairment in the patterns of treatment response to memantine combined with escitalopram compared to escitalopram and placebo.

Mild Cognitive Impairment (MCI)Depression

University of California, Los Angeles115 participantsStarted Oct 2013

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

NCT02648204

This trial is conducted in Asia, Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S1,201 participantsStarted Jan 2016

Tuscumbia, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +206 more locations

Beta Cell Restoration Through Fat Mitigation

Brain Aging and Treatment Response in Geriatric Depression

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Find Trials by Condition in Los Angeles

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Trial of IMO-8400 in Adult Patients With Dermatomyositis

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol